Anderson, RM

Farrell, SH

Truscott, JE

Turner, HC

Yang, J

Parasites & Vectors

PubMed

RM Anderson

HC Turner

SH Farrell

Jie Yang

JE Truscott

Crossref

What is required in terms of mass drug administration to interrupt the transmission of schistosome parasites in regions of endemic infection?

Abstract Background Schistosomiasis is endemic in 54 countries, but has one of the lowest coverages by mass drug administration of all helminth diseases. However, with increasing drug availability through donation, the World Health Organisation has set a goal of increasing coverage to 75 % of at-risk children in endemic countries and elimination in some regions. In this paper, we assess the impact on schistosomiasis of the WHO goals in terms of control and elimination. Methods We use an age-structured deterministic model of schistosome transmission in a human community and the effect of mass drug administration. The model is fitted to baseline data from a longitudinal re-infection study in Kenya and validated against the subsequent re-infection data. We examine the impact on host worm burden of the current treatment trend, extrapolated to meet the WHO goals, and its sensitivity to uncertainty in important parameters. We assess the feasibility of achieving elimination. Results Model results show that the current treatment trend, extrapolated to the WHO goals, is able to greatly reduce host worm burdens. If coverage is continued at the same level beyond 2020, elimination is possible for low to moderate transmission settings, where transmission intensity is defined by the basic reproduction number, R0. Low levels of adult coverage have a significant impact on worm burden in all settings. Model validation against the re-infection survey demonstrates that the age-structured model is able to match post-treatment data well in terms of egg output, but that some details of re-infection among school children and young adults are not currently well represented. Conclusions Our work suggests that the current WHO treatment goals should be successful in bringing about a major reduction in schistosome infection in treated communities. If continued over a 15 year period, they are likely to result in elimination, at least in areas with lower transmission

Directory of Open Access Journals

Springer - Publisher Connector

BackgroundSchistosomiasis is endemic in 54 countries, but has one of the lowest coverages by mass drug administration of all helminth diseases. However, with increasing drug availability through donation, the World Health Organisation has set a goal of increasing coverage to 75 % of at-risk children in endemic countries and elimination in some regions. In this paper, we assess the impact on schistosomiasis of the WHO goals in terms of control and elimination.MethodsWe use an age-structured deterministic model of schistosome transmission in a human community and the effect of mass drug administration. The model is fitted to baseline data from a longitudinal re-infection study in Kenya and validated against the subsequent re-infection data. We examine the impact on host worm burden of the current treatment trend, extrapolated to meet the WHO goals, and its sensitivity to uncertainty in important parameters. We assess the feasibility of achieving elimination.ResultsModel results show that the current treatment trend, extrapolated to the WHO goals, is able to greatly reduce host worm burdens. If coverage is continued at the same level beyond 2020, elimination is possible for low to moderate transmission settings, where transmission intensity is defined by the basic reproduction number, R0. Low levels of adult coverage have a significant impact on worm burden in all settings. Model validation against the re-infection survey demonstrates that the age-structured model is able to match post-treatment data well in terms of egg output, but that some details of re-infection among school children and young adults are not currently well represented.ConclusionsOur work suggests that the current WHO treatment goals should be successful in bringing about a major reduction in schistosome infection in treated communities. If continued over a 15 year period, they are likely to result in elimination, at least in areas with lower transmission

Yang, Jie

Repository@Hull - Worktribe

Background: Schistosomiasis is endemic in 54 countries, but has one of the lowest coverages by mass drug
administration of all helminth diseases. However, with increasing drug availability through donation, the World
Health Organisation has set a goal of increasing coverage to 75 % of at-risk children in endemic countries and
elimination in some regions. In this paper, we assess the impact on schistosomiasis of the WHO goals in terms of
control and elimination.
Methods: We use an age-structured deterministic model of schistosome transmission in a human community and
the effect of mass drug administration. The model is fitted to baseline data from a longitudinal re-infection study in
Kenya and validated against the subsequent re-infection data. We examine the impact on host worm burden of the
current treatment trend, extrapolated to meet the WHO goals, and its sensitivity to uncertainty in important
parameters. We assess the feasibility of achieving elimination.
Results: Model results show that the current treatment trend, extrapolated to the WHO goals, is able to greatly
reduce host worm burdens. If coverage is continued at the same level beyond 2020, elimination is possible for low
to moderate transmission settings, where transmission intensity is defined by the basic reproduction number, R0.
Low levels of adult coverage have a significant impact on worm burden in all settings. Model validation against the
re-infection survey demonstrates that the age-structured model is able to match post-treatment data well in terms
of egg output, but that some details of re-infection among school children and young adults are not currently well
represented.
Conclusions: Our work suggests that the current WHO treatment goals should be successful in bringing about a
major reduction in schistosome infection in treated communities. If continued over a 15 year period, they are likely
to result in elimination, at least in areas with lower transmission

Spiral - Imperial College Digital Repository

RM Anderson (3564587)

HC Turner (3564593)

SH Farrell (3564938)

Jie Yang (121778)

JE Truscott (3564590)

The Francis Crick Institute

Additional file 1: of What is required in terms of mass drug administration to interrupt the transmission of schistosome parasites in regions of endemic infection?

file:///data/remote/core/dit/data/Springer-OA/pdf/a0c/aHR0cDovL2xpbmsuc3ByaW5nZXIuY29tLzEwLjExODYvczEzMDcxLTAxNS0xMTU3LXkucGRm.pdf

What is required in terms of mass drug administration to interrupt the transmission of schistosome parasites in regions of endemic infection?

Abstract

Similar works

Full text

Available Versions